{
  "ticker": "GILD",
  "company_name": "Gilead Sciences, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04155749",
      "title": "Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Relapsed and Refractory Multiple Myeloma",
      "start_date": "2019-12-23",
      "completion_date": "2026-06",
      "enrollment": 0,
      "sponsor": "Kite, A Gilead Company"
    },
    {
      "nct_id": "NCT05568095",
      "title": "A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Advanced Upper Gastrointestinal Tract Adenocarcinoma",
      "start_date": "2022-11-21",
      "completion_date": "2026-06",
      "enrollment": 0,
      "sponsor": "Arcus Biosciences, Inc."
    },
    {
      "nct_id": "NCT05327530",
      "title": "A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Locally Advanced or Metastatic Urothelial Carcinoma",
      "start_date": "2022-08-17",
      "completion_date": "2026-06-25",
      "enrollment": 0,
      "sponsor": "EMD Serono Research & Development Institute, Inc."
    },
    {
      "nct_id": "NCT05833867",
      "title": "Adaptive RADiation Therapy with Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma",
      "start_date": "2024-04-01",
      "completion_date": "2027-10",
      "enrollment": 0,
      "sponsor": "Shilpa Gupta, MD"
    },
    {
      "nct_id": "NCT04986579",
      "title": "Scalp Cooling in MBC",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Metastatic Breast Cancer, Chemotherapy-induced Alopecia",
      "start_date": "2021-10-07",
      "completion_date": "2028-06-01",
      "enrollment": 0,
      "sponsor": "Dana-Farber Cancer Institute"
    },
    {
      "nct_id": "NCT03846310",
      "title": "A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung, Sensitizing EGFR Gene Mutation",
      "start_date": "2019-04-01",
      "completion_date": "2024-11-18",
      "enrollment": 0,
      "sponsor": "Arcus Biosciences, Inc."
    },
    {
      "nct_id": "NCT05633667",
      "title": "Study of Novel Treatment Combinations in Patients With Lung Cancer",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer",
      "start_date": "2023-03-16",
      "completion_date": "2029-09",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT05814432",
      "title": "Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Disseminated Histoplasma Capsulatum Infection, AIDS and Infections, Immunosuppression, Fungal Infection",
      "start_date": "2025-01-16",
      "completion_date": "2026-11-28",
      "enrollment": 0,
      "sponsor": "Federal University of Health Science of Porto Alegre"
    },
    {
      "nct_id": "NCT02691728",
      "title": "Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease",
      "status": "UNKNOWN",
      "phase": "PHASE4",
      "condition": "Chronic Hepatitis C",
      "start_date": "2016-02",
      "completion_date": "2017-05",
      "enrollment": 0,
      "sponsor": "Peter J. Ruane, M.D., Inc."
    },
    {
      "nct_id": "NCT05502237",
      "title": "Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Non-small Cell Lung Cancer",
      "start_date": "2022-10-12",
      "completion_date": "2028-06",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1": 8,
      "PHASE3": 10,
      "PHASE2": 18,
      "PHASE4": 3,
      "": 4,
      "NA": 3,
      "PHASE1, PHASE2": 4
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 7,
      "RECRUITING": 13,
      "COMPLETED": 23,
      "UNKNOWN": 2,
      "TERMINATED": 2,
      "NOT_YET_RECRUITING": 1,
      "WITHDRAWN": 2
    },
    "active_trials": 20,
    "completed_trials": 23,
    "conditions": [
      "Advanced Breast Cancer, Metastatic Breast Cancer",
      "Advanced Solid Tumors",
      "Advanced Upper Gastrointestinal Tract Adenocarcinoma",
      "Atrial Fibrillation, Heart Failure",
      "Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer",
      "Chronic Hepatitis B",
      "Chronic Hepatitis C",
      "Chronic Lymphocytic Leukemia",
      "Coronary Artery Disease",
      "Covid19",
      "Cystic Fibrosis",
      "Cystic Fibrosis, CF, Lung Infection, Pseudomonas Aeruginosa",
      "Disseminated Histoplasma Capsulatum Infection, AIDS and Infections, Immunosuppression, Fungal Infection",
      "Fungemia",
      "Gastrointestinal Tract Malignancies",
      "HIV Infections",
      "HIV Prevention",
      "HIV, Cardiovascular Diseases",
      "HIV-1 Infection",
      "HIV-1-infection",
      "HIV/AIDS",
      "Head and Neck Squamous Cell Carcinoma",
      "Healthy Participants",
      "Hepatitis C, Chronic",
      "Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma",
      "Locally Advanced or Metastatic Urothelial Carcinoma",
      "Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer",
      "Metastatic Breast Cancer",
      "Metastatic Breast Cancer, Chemotherapy-induced Alopecia",
      "Metastatic Colorectal Cancer",
      "Metastatic Non Small Cell Lung Cancer",
      "Mucormycosis",
      "Multiple Myeloma",
      "Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung, Sensitizing EGFR Gene Mutation",
      "Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Squamous Non Small Cell Lung Cancer, Lung Cancer",
      "Non-small Cell Lung Cancer",
      "Primary Visceral Leishmaniasis",
      "Prostatic Neoplasms, Castration-Resistant, Androgen-Resistant Prostatic Neoplasms, Castration Resistant Prostatic Neoplasms, Prostatic Cancer, Castration-Resistant",
      "Refractory Diffuse Large B Cell Lymphoma",
      "Relapsed and Refractory Multiple Myeloma",
      "Relapsed/Refractory Mantle Cell Lymphoma",
      "Solid Tumor, Unspecified, Adult",
      "Talaromycosis",
      "Triple Negative Breast Cancer",
      "Ulcerative Colitis",
      "Urothelial Carcinoma, Bladder Cancer"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:43:02.219655",
    "search_query": "Gilead Sciences, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Gilead+Sciences,+Inc."
  }
}